Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.19
+0.24 (1.34%)
At close: Jun 12, 2026, 4:00 PM EDT
17.98
-0.21 (-1.16%)
After-hours: Jun 12, 2026, 5:15 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.01 billion as of June 12, 2026. Its market cap has increased by 116.14% in one year.
Market Cap
3.01B
Enterprise Value
2.20B
1-Year Change
116.14%
Ranking
Category
Stock Price
$18.19
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.01B, an increase of 280.21%. That is a compound annual growth rate of 26.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.01B | -6.63% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.34B |
| Telix Pharmaceuticals | 3.26B |
| Relay Therapeutics | 3.23B |
| Alumis | 3.08B |
| Structure Therapeutics | 3.05B |
| Arcutis Biotherapeutics | 3.05B |
| Arcus Biosciences | 2.99B |
| Beam Therapeutics | 2.89B |